/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, announces.
Researchers at Queen's University Belfast have designed a new bandage treatment, known as a scaffold, to treat diabetic foot ulcers, which is cost-effective while improving patient outcomes.
Ever since 70-year-old Vince Gauci was diagnosed with diabetes 15 years ago, he has been aware that he may one day develop foot ulcers – the cause of abou
Esmolol, a widely available and cheap beta-blocker, shows statistically significant superiority over the standard of care for diabetic foot ulcers, according to new, potentially game-changing phase 3 data.
Performing proactive surgery to adjust the mechanics of the foot, appears to be effective to treat diabetic foot ulcers, a common and debilitating complication of diabetes, without the potential complications and at significantly lower cost compared to conservative management.